Organon Pharma Indonesia Tbk. vs Temas Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Temas Tbk. trades at Rp146 (market cap 8.44T, 6.33M 24h volume). The key difference: Temas Tbk. is far larger — about 80.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TMAS | |
|---|---|---|
Market Cap | 104.4B | 8.44T |
Volume | — | 6.33M |
Lot | — | 63.31K |
Turnover | — | 913.97M |
Average Price | — | 144.37 |
Value | — | 913.97M |
Indicative Equilibrium Price | — | 146 |
Indicative Equilibrium Volume | — | 1.77K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Pelayaran Tempuran Emas Tbk (company) was established under the name of PT Tempuran Emas based on Notarial Deed No. 252 dated September 17, 1987 of Misahardi Wilamarta, S.H.The latest amendment of the Articles of Association was registered through Notary Deed No. 26 dated April 14, 2003 of Fathiah Helmi, SH, to comply with the Corporate Law No. 1/1995. The amendment includes, among others, par value of share, increase in capital paid up. The amendment was approved by Ministry of Justice in the Decision Letter No C-08530.HT.01.04.TH.2003 dated 17 April 2003 and was published in the State Gazette No. 49, Supplement No. 4860 dated June 20, 2003.
Read more on TMAS →